If your tirzepatide-related headache persists or becomes severe, report it to your doctor immediately, as it may indicate an underlying issue or require a treatment adjustment
USP Regulations Noom has carefully selected pharmacy partners that are held to strict standards to ensure quality and compliance
Depending on your reason for taking it, insurance may cover some or all of the cost
You're already at goal weight

Essential Grocery List for GLP-1 Success Proteins (always have on hand): Chicken breast or tenderloins Ground turkey (93% lean) Salmon or cod fillets Canned tuna or salmon (in water) Eggs (lots of them) Greek yogurt (plain, full-fat or 2%) Cottage cheese Tofu or tempeh (if you eat plant-based) Protein powder (whey or plant-based) Rotisserie chicken (convenience saver) Vegetables (fresh and frozen): Spinach and mixed greens Broccoli, cauliflower, Brussels sprouts Bell peppers, cucumbers, tomatoes Carrots, celery, zucchini Frozen vegetable mixes (steam-in-bag for convenience) Healthy carbs: Oats (quick or old-fashioned) Quinoa Brown rice or wild rice Sweet potatoes Beans (canned or dried) Whole grain bread or wraps Fruits: Berries (fresh or frozen) Apples, oranges, bananas Frozen fruit for smoothies Healthy fats: Olive oil or avocado oil Avocados Nuts and seeds (pre-portioned) Natural peanut or almond butter Batch Cooking for GLP-1 Users The key with meal prep on GLP-1s is flexibilityyou want options ready but not so much food that it overwhelms you when appetite is low

Side Effects Comparison# Retatrutide Side Effects# Phase 2 trial data revealed: Gastrointestinal : Nausea (24-46%), diarrhea (16-26%), vomiting (9-20%), constipation (6-16%) Heart rate : Small mean increase (2-4 bpm) potentially related to glucagon receptor activation Injection site reactions : Mild and transient Hepatic : Transient elevations in liver enzymes observed Discontinuation rate : 6-10% due to adverse events in Phase 2 The glucagon receptor component introduces a unique side effect profile compared to GLP-1-only or GIP/GLP-1 dual agonists